MPA Pharma GmbH
MPA Pharma GmbH, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative medical products. Founded in 2005, the company has established a strong presence in various operational regions across Europe, focusing on advanced therapeutic solutions. With a commitment to quality and efficacy, MPA Pharma offers a range of unique products, including specialised medications and healthcare solutions tailored to meet the needs of healthcare professionals and patients alike. The company is recognised for its dedication to research and development, which has led to significant advancements in its product offerings. Notable achievements include strategic partnerships and a growing market position, solidifying MPA Pharma's reputation as a trusted name in the pharmaceutical sector. Through its innovative approach, MPA Pharma continues to contribute to the improvement of health outcomes across its operational territories.
DitchCarbon Score
How does MPA Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MPA Pharma GmbH's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MPA Pharma GmbH's reported carbon emissions
MPA Pharma GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MPA Pharma GmbH may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, MPA Pharma GmbH may need to consider developing and communicating its climate strategies to align with global standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MPA Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
